• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Sunday, January 29, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Rapid, temperature-sensitive hemorrhage control for traumatic wounds

Bioengineer by Bioengineer
December 21, 2022
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

(LOS ANGELES) – December 21, 2022 – As outlined in their recent publication in Biomaterials Science, researchers from the Terasaki Institute for Biomedical Innovation, (TIBI), have developed an injectable, temperature sensitive, shear-thinning hydrogel (T-STH) hemostat that works rapidly at body temperature to stop bleeding from a wound. This technology allows anyone to treat victims of traumatic injuries immediately and effectively. Once patient stability is achieved, the T-STH hemostat can easily be removed using a cold saline wash without leaving residues or causing re-bleeding of the wound. The saline wash also allows for removal of any debris lodged into the wound.

The Terasaki Institute for Biomedical Innovation (TIBI) has developed thermoresponsive shear-thinning hydrogel (T-STH) hemostats for minimally invasive treatment of external hemorrhages

Credit: Terasaki Institute for Biomedical Innovation

(LOS ANGELES) – December 21, 2022 – As outlined in their recent publication in Biomaterials Science, researchers from the Terasaki Institute for Biomedical Innovation, (TIBI), have developed an injectable, temperature sensitive, shear-thinning hydrogel (T-STH) hemostat that works rapidly at body temperature to stop bleeding from a wound. This technology allows anyone to treat victims of traumatic injuries immediately and effectively. Once patient stability is achieved, the T-STH hemostat can easily be removed using a cold saline wash without leaving residues or causing re-bleeding of the wound. The saline wash also allows for removal of any debris lodged into the wound.

This treatment is applicable for any traumatic wound, but is especially relevant in treating battlefield wounds, as hemorrhage is the leading cause of potentially survivable deaths from trauma in the battlefield. In the battlefield, immediate access to medical care is delayed, and wounded soldiers are often vulnerable to excessive and often fatal severe blood loss (hemorrhage). It is therefore critical to immediately respond to wounded personnel by a simple method that can provide rapid and sustained hemorrhage control for a variety of wounds.

To date, there are many forms of commercially available hemostats, including sponges, powders, sheets, gauzes, and hydrogels, which exhibit effective hemorrhage control. But none of them, including the gold standard QuikClot Combat Gauze®, can provide fast, temperature-sensitive treatment of hemorrhage in a controllable manner.

“We need something simple, yet effective, that can be easily deployable on the battlefield,” commented Marvin Mecwan, Ph.D., a postdoctoral researcher at TIBI and the lead scientist of this project.

The team chose to use a polymer called poly(N-isopropyl acrylamide), due to its temperature-sensitive mechanical properties. Laponite, a blood coagulating agent, was added to impart the composite hydrogel with shear-thinning capabilities – the ability to deform under stress and quickly self-recover afterwards.

In initial experiments, an optimized T-STH formulation was produced, and it was demonstrated that the material could stop bleeding when subjected to quickly changing temperatures, such as during the treatment of traumatic wounds. After injection into the body, the T-STH becomes a solid, and hemorrhage-controlling material; when exposed to a cold saline wash, it changes to a soluble material that can easily be washed away. Furthermore, this formulation showed 50% reduced blood clot time over negative controls, was shown to be non-toxic, and degraded at rates favorable for short-term hemorrhage control.  

The T-STH formulation was further tested in a laboratory model set up to mimic human blood flow. These experiments were conducted using human blood warmed to body temperature. Blood from simulated injuries were collected; the results showed that the T-STH was significantly able to reduce blood loss at the injury sites and form an effective plug against further bleeding at different blood flow rates.

These results were reproduced using mouse models with bleeding injuries; the T-STH exhibited clotting times and blood loss similar to that of a leading commercial hemostat, Floseal.

The TIBI team’s T-STH is an optimal choice for rapid, first-round treatment for any emergency or time-critical external injuries. In addition, there is a potential for improvement by the addition of faster coagulants, antibiotics for infection control, and molecules that promote tissue regeneration. In addition, there are possibilities for a sprayable version of the T-STH to treat lacerations and abrasions.

“The development of a temperature sensitive hemostat enhances the effectiveness and simplicity of immediate treatment for traumatic injury and has the potential to save many lives,” said Ali Khademhosseini, Ph.D., TIBI’s Director and CEO. “It is one of many ongoing and impactful research efforts from our biomaterials platform.”



Journal

Biomaterials Science

DOI

10.1039/D2BM01559E

Method of Research

Experimental study

Subject of Research

Not applicable

Article Title

Thermoresponsive shear-thinning hydrogel (T-STH) hemostats for minimally invasive treatment of external hemorrhages

Article Publication Date

8-Dec-2022

Share12Tweet8Share2ShareShareShare2

Related Posts

World-first guidelines created to help prevent heart complications in children during cancer treatment

World-first guidelines created to help prevent heart complications in children during cancer treatment

January 29, 2023
Schematic of solar wind charge exchange events.

Simulations reproduce complex fluctuations in soft X-ray signal detected by satellites

January 28, 2023

Measles virus ‘cooperates’ with itself to cause fatal encephalitis

January 27, 2023

A new Assay screening method shows therapeutic promise for treating auto-immune disease

January 27, 2023

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    64 shares
    Share 26 Tweet 16
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

World-first guidelines created to help prevent heart complications in children during cancer treatment

Simulations reproduce complex fluctuations in soft X-ray signal detected by satellites

Measles virus ‘cooperates’ with itself to cause fatal encephalitis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 42 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In